A Simple Key For BCAT-IN-4 Unveiled
The increased difference from placebo seen to the IFN-high sufferers supports the speculation the peripheral blood IFN exam position displays systemic type I IFN action. In contrast, for IFN-small patients there was a more compact distinction in response prices concerning the placebo as well as the 200 mg or 1200 mg every month sifalimumab teams.